title: [Effect of combination chemotherapy of tegafur, adriamycin and cisplatin on patients with advanced relapsing prostatic carcinoma and advanced bladder tumor].
authors.forename: K
authors.initials: K
authors.lastname: Yoshida
authors.forename: Y
authors.initials: Y
authors.lastname: Nakame
authors.forename: S
authors.initials: S
authors.lastname: Horiuchi
authors.forename: F
authors.initials: F
authors.lastname: Kaneoya
authors.forename: T
authors.initials: T
authors.lastname: Kuroda
authors.forename: A
authors.initials: A
authors.lastname: Tanoiri
authors.forename: M
authors.initials: M
authors.lastname: Koizumi
authors.forename: M
authors.initials: M
authors.lastname: Takahashi
authors.forename: T
authors.initials: T
authors.lastname: Negishi
authors.forename: H
authors.initials: H
authors.lastname: Saitoh
mesh_terms: D000230:Adenocarcinoma / Q000188:drug therapy*; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002295:Carcinoma, Transitional Cell / Q000188:drug therapy*; D002945:Cisplatin / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011471:Prostatic Neoplasms / Q000188:drug therapy*; D005641:Tegafur / Q000008:administration & dosage; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy*
chemical_list: D005641:Tegafur; D004317:Doxorubicin; D002945:Cisplatin